Serum BP180 and BP230 autoantibodies in Alzheimer’s disease: diagnostic and cognitive associations in a retrospective study [PDF]
BackgroundTo assess the prevalence and diagnostic value of serum anti-BP180 and anti-BP230 antibodies in Alzheimer’s Disease (AD) and their relationship with cognitive function.MethodsWe conducted a retrospective case–control study comprising 279 ...
Sha Jin +4 more
doaj +2 more sources
Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease predominantly affecting elderly patients and carries significant morbidity and mortality.
, Kyle T Amber, Borradori Luca
exaly +3 more sources
BP230-Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center. [PDF]
International Journal of Dermatology, Volume 65, Issue 7, Page 1460-1462, July 2026.
Maglie R +11 more
europepmc +2 more sources
A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor
Bullous pemphigoid (BP) is a cutaneous autoimmune blistering disorder. Recently, it has been reported that dipeptidyl peptidase-4 inhibitors (DPP4i) is associated with the development of BP (DPP4i-BP). Patients with DPP4i-BP have autoantibodies (autoAbs)
Tadahiro Kobayashi +2 more
exaly +2 more sources
Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid [PDF]
BackgroundA novel fully automated chemiluminescent immunoassay (CLIA) has been developed to quantify autoantibodies specific for desmogleins (Dsg1, Dsg3), BP180, and BP230, key target antigens in pemphigus and bullous pemphigoid.
Na Zhang +14 more
doaj +2 more sources
Diagnostic Agreement in Subepidermal Blistering Diseases: Is ELISA Test Reliable as Direct Immunofluorescence? A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. [PDF]
ABSTRACT Objectives Direct immunofluorescence (DIF) is the gold standard for diagnosing subepidermal blistering diseases (SBDs). However, DIF requires specialized expertise; therefore, alternative immunological methods such as enzyme‐linked immunosorbent assays (ELISA) are worth exploring. The aim of this review was to evaluate the diagnostic agreement
Patini R +9 more
europepmc +2 more sources
The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response. [PDF]
ABSTRACT Bullous pemphigoid (BP) is an autoimmune blistering disease whereby the cutaneous antigens BP180 and BP230 are targeted by autoantibodies. Skin lesions in BP are characterized by an abundance of eosinophils. We recently demonstrated that the treatment of keratinocytes with antibodies from patients with BP induces a robust inflammatory response
Mansini AP +10 more
europepmc +2 more sources
Background In ocular mucous membrane pemphigoid (MMP) direct immunofluorescence (DIF) represents the gold standard for definitive diagnosis. However, up to 50% of ocular MMP cases do not meet the immunopathological criteria.
Andrea Gabusi +6 more
doaj +2 more sources
Detection of Diagnostic Antibodies in Immune-Mediated Diseases: A Focus on Antigens and Technologies. [PDF]
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Bracci S +5 more
europepmc +2 more sources
Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment [PDF]
ObjectiveThis study aimed to explore the relationship between serum levels of interleukin-17 (IL-17), interleukin-18 (IL-18), interleukin-22 (IL-22), interleukin-25 (IL-25), anti-BP180 antibodies, anti-BP230 antibodies, and immunoglobulin E (IgE) and the
Xinyi Hong +23 more
doaj +2 more sources

